Lytica Labs Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 3.00 Cr
as on 16-12-2024
- Company Age 7 Year, 23 Days
- Last Filing with ROC 31 Mar 2024
- Revenue -6.67%
(FY 2022)
- Profit -16.67%
(FY 2022)
- Net Worth 2.71%
(FY 2022)
- Total Assets 3.85%
(FY 2022)
About Lytica Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Subbarao Kattamuri and Sushma Kattamuri serve as directors at the Company.
- CIN/LLPIN
U74999TG2017PTC120942
- Company No.
120942
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Lytica Labs?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Subbarao Kattamuri | Director | 01-Dec-2017 | Current |
Sushma Kattamuri | Director | 02-Sep-2024 | Current |
Financial Performance of Lytica Labs.
Lytica Labs Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 6.67% decrease. The company also saw a substantial fall in profitability, with a 16.67% decrease in profit. The company's net worth moved up by a moderate rise of 2.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
What is the Ownership and Shareholding Structure of Lytica Labs?
In 2020, Lytica Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Evertogen Life Sciences LimitedActive 11 years 11 months
Subbarao Kattamuri and Sushma Kattamuri are mutual person
- K.R.R. Drugs & Intermediates Private LimitedActive 22 years 10 months
Subbarao Kattamuri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lytica Labs?
Unlock and access historical data on people associated with Lytica Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lytica Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lytica Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.